Low-titre auto-antibodies predict autoimmune disease during interferon-α treatment of chronic hepatitis C
- 19 April 2002
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 14 (5) , 419-422
- https://doi.org/10.1046/j.1440-1746.1999.01896.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Serum Soluble CD23 but Not IL8, IL10, GM-CSF, or IFN-γ Is Elevated in Patients with Hepatitis C InfectionClinical Immunology and Immunopathology, 1997
- Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon‐α therapyClinical Endocrinology, 1996
- Hepatitis C: A Multifaceted Disease: Review of Extrahepatic ManifestationsAnnals of Internal Medicine, 1995
- Clinical associations between thyroid and liver diseasesJournal of Gastroenterology and Hepatology, 1995
- Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2aActa Endocrinologica, 1995
- Immunologic features and HLA associations in chronic viral hepatitisGastroenterology, 1995
- Hepatitis C virus six years onThe Lancet, 1994
- High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapyHepatology, 1993
- Non-organ specific autoantibodies associated with chronic C virus hepatitisJournal of Hepatology, 1993
- Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfaGastroenterology, 1992